December 1, 2009 - The FDA has finally come out and decided on CFS Drug, Ampligen
The Ruling? No
Shares of Hemispherx Biopharma, Inc. (HEB) are trading in the $0.70's tonight in afterhours in the wake of this news.
This doesn't appear over quite yet as Hemispherx Biopharma, Inc. is requesting a meeting with the FDA.
Link
Hemispherx Biopharma Receives Complete Response Letter from FDA on Ampligen® New Drug Application for Chronic Fatigue Syndrome
Hemispherx Biopharma, Inc. (NYSE Amex: HEB) (the “Company” or “Hemispherx”), announced that it received a Complete Response Letter from the US Food and Drug Administration (“FDA”) which describes specific additional recommendations related to the Ampligen® NDA. In accordance with its 2008 “Complete Response” procedure, the FDA reviewers determined that they cannot approve the application in its present form and provided specific recommendations to address the outstanding issues. Hemispherx is carefully reviewing the Complete Response letter and will seek an expedited meeting with the FDA to discuss its recommendations. Management is pleased to have received specific advice on the remaining issues and is looking forward to making a thorough but expedited response its top priority, and plans to take all appropriate steps to seek approval and commercialization of Ampligen®.
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Showing posts with label heb. Show all posts
Showing posts with label heb. Show all posts
Tuesday, December 1, 2009
Saturday, October 17, 2009
Hemispherx Biopharma HEB Stock Analysis
HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for October 19, 2009Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 10/19/09
Resistance Levels: $1.90, $2.16
Support Levels: $1.75, $1.64
Chart - http://stockcharts.com/
Discuss Stocks - http://stockstobuy.org/
Hemispherx Biopharma, Inc. (HEB) continues the downtrend that began in July when it became apparent that the Ampligen FDA decision would be delayed for awhile. HEB closed back below the 10 day moving average on Friday so I would be avoiding the stock right now. There is resistance between $1.85-$1.90, so if HEB breaks back above $1.90, I will jump in for a quick trade. Keep an eye on $2.16 & $2.24. If HEB would gain momentum and break these two prices on heavy volume, this would be a sign of a trend reversal and I'd look for $2.54-$2.55 to be retested. Support is located at $1.75 & $1.64 but like I said earlier, as long as HEB trades below the 10 day moving average, I will be avoiding it. For More Technical Analysis - Go Here
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Friday, October 9, 2009
HEB Stock Technical Analysis
HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for October 9, 2009Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 10/9/09
Resistance Levels: $2.24, $2.54
Support Levels: $2.00, $1.90
Discuss Stocks - http://stockstobuy.org/
Hemispherx Biopharma, Inc. (HEB) closed above the 10 day moving average on Thursday and looks poised to jump above the 50 day moving average today. The next resistance levels I would be watching out for are $2.24 & $2.54. If the stock can close over $2.54, I feel it could retest $3 per share. On the downside, support is located at $1.90. For More Technical Analysis - Go Here
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Saturday, September 26, 2009
HEB Stock Analysis September 28, 2009 9/28/09
HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for September 28, 2009Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 9/28/09
Resistance Levels: $2.25, $2.54
Support Levels: $2.00, $1.86
Chart - http://stockcharts.com/
Discuss Stocks - http://stockstobuy.org/
HEB stock continues to hover around the $2 level. The company expects the FDA to come out with a decision on their CFS drug sometime this fall.
Resistance is located around $2.24, if I see HEB close above $2.25, I will get back into the stock. This would be a huge trend reversal because HEB hasn't closed over $2.25 since July.
On the downside, pullbacks to $1.86 must continue to hold. For More Technical Analysis - Go Here
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Thursday, September 17, 2009
HEB Stock Analysis September 17, 2009 9/17/09
HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for September 17, 2009Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 9/17/09
Resistance Levels: $2.24, $2.54
Support Levels: $2.00
Chart - http://stockcharts.com/
Discuss Stocks - http://stockstobuy.org/
Hemispherx Biopharma, Inc. (HEB) stock closed over the the 10 and 50 day moving averages yesterday which is very bullish. I am now watching resistance at yesterdays high which was $2.24. If HEB can break above $2.24, we could be in the early stages of a new uptrend. Pullbacks below $2 are now a strong buy. Keep an eye on $2.24 & $2.54 on the upside. For More Technical Analysis - Go Here
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Saturday, August 29, 2009
HEB Stock Analysis August 31, 2009 8/31/09
HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for August 31, 2009Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 8/31/09
Resistance Levels: $2.11, $2.20, $2.50
Support Levels: $1.99, $1.94, $1.86
Chart - http://stockcharts.com/
Discuss Stocks - http://stockstobuy.org/
HEB is back trading over the 10 day moving average which is bullish. The stock has been having problems closing over the 50 day moving average for the past month so when you see this happen, a surge should follow. I am currently back in the stock and will keep a tight stop at $1.85. After the 50 day moving average, there is also resistance located between $2.50-$2.60. If HEB can bust up through that area, you could see the momentum traders pile back into the stock again. With the swine flu threat out there, HEB should be hot going into the fall. For More Technical Analysis - Go Here
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Saturday, August 15, 2009
HEB Stock Analysis August 17, 2009 8/17/09
HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for August 17, 2009Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 8/17/09
Resistance Levels: $2.06, $2.34
Support Levels: $2, $1.87, $1.50
Chart - http://stockcharts.com/
Discuss Stocks - http://stockstobuy.org/
HEB stock continues to close under the 10 day moving average as investors await an FDA decision on CFS drug Ampligen due out sometime this fall. As soon as the stock closes above the 10 day moving average, you could see a nice pop. HEB has resistance at the 50 day moving average as well. A close above $2.34 will also attract some big buyers as this would be a very bullish indicator. As long as Hemispherx Biopharma trades below these two moving averages, I will be staying away but will always be watching. For More Technical Analysis - Go Here
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Tuesday, July 21, 2009
Hemispherx HEB Conference Call 7/22/09 - July 22, 2009
Hemispherx Biopharma, Inc. (HEB) stock is breaking out today, $2.92 Up 17.50%, one day before a conference call to update shareholders on influenza prevention. HEB is breaking out above the previous June 2009 high of $2.85 which is bullish.Ampligen: HEB is also waiting for an FDA decision on their CFS drug Ampligen. Investors and Traders could be getting in with anticipation that we will hear an positive update on Ampligen. After seeing what happened to Human Genome Sciences Inc. (HGSI), an FDA approval for Ampligen could be explosive for HEB.
Update - 7/22/09 - " Still Waiting on Response from FDA on Ampligen "
HEMISPHERX BIOPHARMA TO PROVIDE UPDATE ON GLOBAL PANDEMIC INFLUENZA PREVENTION / TREATMENT INITIATIVES
Philadelphia, PA, Monday, July 20, 2009: Hemispherx Biopharma (NYSE AMEX: HEB) will provide an update on its Influenza research initiatives via teleconference on Wednesday, July 22, 2009, at 10:00 AM EDT. Initiatives to be discussed will include experimental programs planned or underway in Pacific Rim countries, Australia, South America and the United States. Background information may be sourced at Wall Street Journal, July 18/19, 2009, p. A3.
Hemispherx’s Medical Director, CEO, and the Managing Director of the Sage Group, a health care consulting firm retained by Hemispherx, will participate. Investigational products and protocols to be discussed will include Hemispherx’s Ampligen® (poly I: poly C12U), Alferon N (a natural cocktail of alpha 2 type interferons, FDA approved for treatment of refractory HPV) and Alferon LDO, an experimental formulation of Alferon-N for oral delivery. Full Article
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Friday, July 3, 2009
HEB Stock Analysis July 6, 2009 7/6/09
HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for July 6, 2009Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 7/6/09
Resistance Levels: $2.85, $3.00
Support Levels: $2.42, $2
Chart - http://stockcharts.com/
Discuss Stocks - http://stockstobuy.org/
Still waiting for FDA approval decision on Ampligen - HEB is back trading above the 10 day moving average but has failed to close back above $3. When this happens, you could see major spikes higher. HEB has only closed above $3 two times on this run, so a close above $3 would be huge technically. Pullbacks to the 50 day moving average can be bought unless the FDA rejects the Ampligen drug in which case HEB stock will go back under $1. For More Technical Analysis - Go Here
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Tuesday, June 30, 2009
Top Penny Stocks July 2009 Stock Gainers
The following is a list of Top Penny Stock Gainers ytd as of July 1, 2009. These are penny stocks located on the NYSE, Nasdaq, and AMEX. This list does not include OTC or Pink Sheets stocks.
Top Penny Stocks List -2009 - July 1, 2009
Discuss Stocks - www.stockstobuy.org
#1 Cell Therapeutics, Inc. ( CTIC ) - $1.72 Up 1129% in 2009
#2 InfoSonics Corporation ( IFON ) - $1.76 Up 604% in 2009
#3 Angiotech Pharmaceuticals, Inc. (USA) ( ANPI ) $1.71 Up 558% in 2009
#4 ValueVision Media, Inc. ( VVTV ) - $1.96 Up 494% in 2009
#5 Pier 1 Imports, Inc. ( PIR ) - $1.99 Up 438% in 2009
#6 Nextwave Wireless Inc. ( WAVE ) - $0.48 Up 438% in 2009
#7 Globalstar, Inc. ( GSAT ) - $1.05 Up 425% in 2009
#8 Rite Aid Corporation ( RAD ) - $1.51 Up 387% in 2009
#9 China Shen Zhou Mining & Resources Inc. ( SHZ ) - $1.39 Up 363 in 2009
#10 Authentidate Holding Corp ( ADAT ) - $1.20 Up 362% in 2009
#11 KowaBunga! Inc. ( KOW ) - $0.27 Up 350% in 2009
#12 Astrotech Corp. ( ASTC ) - $1.15 Up 342% in 2009
#13 Arotech Corporation ( ARTX ) - $1.76 Up 329% in 2009
#14 Navarre Corporation ( NAVR ) - $1.66 Up 315% in 2009
#15 Keryx Biopharmaceuticals ( KERX ) - $0.90 Up 309% in 2009
#16 MDRNA, Inc. ( MRNA ) - $1.38 Up 306% in 2009
#17 Augusta Resource Corp. (USA) ( AZC ) - $1.86 Up 304% in 2009
#18 Zhone Technologies, Inc. ( ZHNE ) - $0.32 Up 300% in 2009
#19 Boise Inc. ( BZ ) - $1.72 Up 300% in 2009
#20 TerreStar Corporation ( TSTR ) - $1.53 Up 283% in 2009
Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stock Forum
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Top Penny Stocks List -2009 - July 1, 2009
Discuss Stocks - www.stockstobuy.org
#1 Cell Therapeutics, Inc. ( CTIC ) - $1.72 Up 1129% in 2009
#2 InfoSonics Corporation ( IFON ) - $1.76 Up 604% in 2009
#3 Angiotech Pharmaceuticals, Inc. (USA) ( ANPI ) $1.71 Up 558% in 2009
#4 ValueVision Media, Inc. ( VVTV ) - $1.96 Up 494% in 2009
#5 Pier 1 Imports, Inc. ( PIR ) - $1.99 Up 438% in 2009
#6 Nextwave Wireless Inc. ( WAVE ) - $0.48 Up 438% in 2009
#7 Globalstar, Inc. ( GSAT ) - $1.05 Up 425% in 2009
#8 Rite Aid Corporation ( RAD ) - $1.51 Up 387% in 2009
#9 China Shen Zhou Mining & Resources Inc. ( SHZ ) - $1.39 Up 363 in 2009
#10 Authentidate Holding Corp ( ADAT ) - $1.20 Up 362% in 2009
#11 KowaBunga! Inc. ( KOW ) - $0.27 Up 350% in 2009
#12 Astrotech Corp. ( ASTC ) - $1.15 Up 342% in 2009
#13 Arotech Corporation ( ARTX ) - $1.76 Up 329% in 2009
#14 Navarre Corporation ( NAVR ) - $1.66 Up 315% in 2009
#15 Keryx Biopharmaceuticals ( KERX ) - $0.90 Up 309% in 2009
#16 MDRNA, Inc. ( MRNA ) - $1.38 Up 306% in 2009
#17 Augusta Resource Corp. (USA) ( AZC ) - $1.86 Up 304% in 2009
#18 Zhone Technologies, Inc. ( ZHNE ) - $0.32 Up 300% in 2009
#19 Boise Inc. ( BZ ) - $1.72 Up 300% in 2009
#20 TerreStar Corporation ( TSTR ) - $1.53 Up 283% in 2009
Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stock Forum
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Friday, May 29, 2009
Top Penny Stocks June 2009 Stock Gainers
The following is a list of Top Penny Stock Gainers ytd as of June 1, 2009.
Top Penny Stocks List -2009 - June 1, 2009
Discuss Stocks - www.stockstobuy.org
#1 Air Transport Services ( ATSG ) - $1.86 Up 933% in 2009
#2 Cell Therapeutics, Inc. ( CTIC ) - $1.43 Up 921% in 2009
#3 Angiotech Pharmaceuticals, Inc. (USA) ( ANPI ) $1.80 Up 592% in 2009
#4 EntreMed, Inc ( ENMD ) - $0.79 Up 393% in 2009
#5 Hemispherx BioPharma, Inc ( HEB ) - $1.69 Up 369% in 2009
#6 Globalstar, Inc. ( GSAT ) - $0.93 Up 365% in 2009
#7 FiberTower Corp ( FTWR ) - $0.75 Up 363% in 2009
#8 Authentidate Holding Corp ( ADAT ) - $1.09 Up 331% in 2009
#9 MDRNA, Inc. ( MRNA ) - $1.46 Up 329% in 2009
#10 Boise Inc. ( BZ ) - $1.74 Up in 305% in 2009
#11 Astrotech Corp. ( ASTC ) - $1.01 Up 288% in 2009
#12 Select Comfort Corp ( SCSS ) - $0.96 Up 284% in 2009
#13 Paramount Gold and Silver Corp ( PZG ) - $1.75 Up 280% in 2009
#14 Rite Aid Corporation ( RAD ) - $1.16 Up 274% in 2009
#15 Kodiak Oil & Gas Corp. ( KOG ) - $1.16 Up 274% in 2009
#16 Anooraq Resources Corporation (USA) ( ANO ) - $1.23 Up 273% in 2009
#17 Edge Petroleum Corp. ( EPEX ) - $0.59 Up 269% in 2009
#18 VIA Pharmaceuticals, Inc. ( VIAP ) - $0.66 Up 267% in 2009
#19 Evergreen Energy Inc. ( EEE ) - $1.02 Up 264% in 2009
#20 Insmed Incorporated ( INSM ) - $1.68 Up 257% in 2009
Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stock Forum
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Top Penny Stocks List -2009 - June 1, 2009
Discuss Stocks - www.stockstobuy.org
#1 Air Transport Services ( ATSG ) - $1.86 Up 933% in 2009
#2 Cell Therapeutics, Inc. ( CTIC ) - $1.43 Up 921% in 2009
#3 Angiotech Pharmaceuticals, Inc. (USA) ( ANPI ) $1.80 Up 592% in 2009
#4 EntreMed, Inc ( ENMD ) - $0.79 Up 393% in 2009
#5 Hemispherx BioPharma, Inc ( HEB ) - $1.69 Up 369% in 2009
#6 Globalstar, Inc. ( GSAT ) - $0.93 Up 365% in 2009
#7 FiberTower Corp ( FTWR ) - $0.75 Up 363% in 2009
#8 Authentidate Holding Corp ( ADAT ) - $1.09 Up 331% in 2009
#9 MDRNA, Inc. ( MRNA ) - $1.46 Up 329% in 2009
#10 Boise Inc. ( BZ ) - $1.74 Up in 305% in 2009
#11 Astrotech Corp. ( ASTC ) - $1.01 Up 288% in 2009
#12 Select Comfort Corp ( SCSS ) - $0.96 Up 284% in 2009
#13 Paramount Gold and Silver Corp ( PZG ) - $1.75 Up 280% in 2009
#14 Rite Aid Corporation ( RAD ) - $1.16 Up 274% in 2009
#15 Kodiak Oil & Gas Corp. ( KOG ) - $1.16 Up 274% in 2009
#16 Anooraq Resources Corporation (USA) ( ANO ) - $1.23 Up 273% in 2009
#17 Edge Petroleum Corp. ( EPEX ) - $0.59 Up 269% in 2009
#18 VIA Pharmaceuticals, Inc. ( VIAP ) - $0.66 Up 267% in 2009
#19 Evergreen Energy Inc. ( EEE ) - $1.02 Up 264% in 2009
#20 Insmed Incorporated ( INSM ) - $1.68 Up 257% in 2009
Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stock Forum
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Tuesday, May 26, 2009
Hemispherx HEB FDA Delay News May 2009
Hemispherx Biopharma, Inc. (HEB) stock is very active this morning, 5/26/09, as the company has issued the following press release:
HEB Stock News - May 26, 2009
HEMISPHERX BIOPHARMA ANNOUNCES POSSIBLE BRIEF DELAY IN FDA ACTION ON AMPLIGEN® NEW DRUG APPLICATION
Philadelphia, PA, Tuesday, May 26, 2009: Hemispherx Biopharma, Inc. (NYSE/AMEX -HEB) today announced that the U.S. Food and Drug administration (“FDA”) has advised the company that it may require up to 1-2 additional weeks to take action beyond the scheduled Prescription Drug User Fee Act action date of May 25, 2009 on the New Drug Application for Ampligen® (Poly I Poly C12U), a selective TLR3 modulator, for the management of Chronic Fatigue Syndrome. Reason for the possible delay was attributed by the Agency to certain staff scheduling changes which might (or might not) delay the report. Accordingly the Company’s development plan for Ampligen® continues as described in the recently filed 10Q and 10K, as the FDA did not request additional information from the Company at this time.
http://www.hemispherx.net/content/investor/default.asp?goto=631
Discuss HEB
More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE
HEB Stock News - May 26, 2009
HEMISPHERX BIOPHARMA ANNOUNCES POSSIBLE BRIEF DELAY IN FDA ACTION ON AMPLIGEN® NEW DRUG APPLICATION
Philadelphia, PA, Tuesday, May 26, 2009: Hemispherx Biopharma, Inc. (NYSE/AMEX -HEB) today announced that the U.S. Food and Drug administration (“FDA”) has advised the company that it may require up to 1-2 additional weeks to take action beyond the scheduled Prescription Drug User Fee Act action date of May 25, 2009 on the New Drug Application for Ampligen® (Poly I Poly C12U), a selective TLR3 modulator, for the management of Chronic Fatigue Syndrome. Reason for the possible delay was attributed by the Agency to certain staff scheduling changes which might (or might not) delay the report. Accordingly the Company’s development plan for Ampligen® continues as described in the recently filed 10Q and 10K, as the FDA did not request additional information from the Company at this time.
http://www.hemispherx.net/content/investor/default.asp?goto=631
Discuss HEB
More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE
Monday, April 27, 2009
Swine Flu Stocks April 27, 2009 4/27/09
The following is a list of swine flu stocks that in some way have potential vaccines or drugs that could potentially help to solve this problem. Nonetheless, these stocks have and will be one fire as long as the swine flu is out there.
Swine Flu Stock List: - Discuss the Swine Flu Stocks at http://stockstobuy.org
Roche Holding Ltd. (ADR) ( RHHBY )
Gilead Sciences, Inc. ( GILD )
GlaxoSmithKline plc (ADR) ( GSK )
Crucell N.V. (ADR) ( CRXL )
Novavax, Inc. ( NVAX )
PURE Bioscience ( PURE )
GenVec Inc. (GNVC)
Generex Biotechnology Corporation ( GNBT )
BioCryst Pharmaceuticals, Inc. ( BCRX )
Hemispherx BioPharma, Inc ( HEB )
AVI BioPharma, Inc ( AVII )
Dynavax Technologies Corporation ( DVAX )
Alpha Pro Tech Ltd. (APT) - they make health protection gear
Sinovac Biotech Ltd. (SVA) - flu vaccine - china
CEL-SCI Corp. (CVM)
Inhibitex Inc. (INHX)
Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stock Message Board
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Swine Flu Stock List: - Discuss the Swine Flu Stocks at http://stockstobuy.org
Roche Holding Ltd. (ADR) ( RHHBY )
Gilead Sciences, Inc. ( GILD )
GlaxoSmithKline plc (ADR) ( GSK )
Crucell N.V. (ADR) ( CRXL )
Novavax, Inc. ( NVAX )
PURE Bioscience ( PURE )
GenVec Inc. (GNVC)
Generex Biotechnology Corporation ( GNBT )
BioCryst Pharmaceuticals, Inc. ( BCRX )
Hemispherx BioPharma, Inc ( HEB )
AVI BioPharma, Inc ( AVII )
Dynavax Technologies Corporation ( DVAX )
Alpha Pro Tech Ltd. (APT) - they make health protection gear
Sinovac Biotech Ltd. (SVA) - flu vaccine - china
CEL-SCI Corp. (CVM)
Inhibitex Inc. (INHX)
Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stock Message Board
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Subscribe to:
Posts (Atom)